Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy

Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy

BackgroundReal‐time monitoring is used to the ends of postmarketing observational research on newly marketed drugs. We implemented a pilot near‐real‐time monitoring program on the test case of oral anticoagulants. Specifically, we evaluated the safety and effectiveness of direct oral anticoagulants...

Full description

Bibliographic Details
Main Authors:	Flavia Mayer, Ursula Kirchmayer, Paola Coletta, Nera Agabiti, Valeria Belleudi, Giovanna Cappai, Mirko Di Martino, Sebastian Schneeweiss, Marina Davoli, Elisabetta Patorno
Format:	Article
Language:	English
Published:	Wiley 2018-03-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	anticoagulant comparative effectiveness drug therapy monitoring pharmacoepidemiology pilot
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.008034

Similar Items

Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
by: Andrea L. Schaffer, et al.
Published: (2019-12-01)

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
by: Aurélie Lenglet, et al.
Published: (2022-12-01)

Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia
by: Machado-Duque ME, et al.
Published: (2023-03-01)

Educational Inequalities in COVID-19 Vaccination: A Cross-Sectional Study of the Adult Population in the Lazio Region, Italy
by: Giulia Cesaroni, et al.
Published: (2022-02-01)

Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial
by: Anne M. Holbrook, et al.
Published: (2022-08-01)

Pharmacoepidemiology /
by: Strom, Brian L.
Published: (2005)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)

High quality process of care increases one-year survival after acute myocardial infarction (AMI): A cohort study in Italy.
by: Martina Ventura, et al.
Published: (2019-01-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01)

The use of glucose‐lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States
by: Mollie E. Wood, et al.
Published: (2022-03-01)

Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population
by: Kubota K, et al.
Published: (2022-04-01)

Non-vitamin K antagonist oral anticoagulants in adults with congenital heart disease
by: Ji-Eun Ban
Published: (2022-09-01)

Priorities for building Australian workforce capacity to leverage population-based, routinely collected data: views from pharmacoepidemiology
by: Derrick Lopez, et al.
Published: (2023-03-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
by: Michele Malagù, et al.
Published: (2023-03-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis
by: S. R. Gilyarevsky
Published: (2021-09-01)

Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy
by: Giada Crescioli, et al.
Published: (2023-12-01)

Anticoagulation Quality and Complications of using Vitamin K Antagonists in the Cardiac Surgery Outpatient Clinic
by: Mário Augusto Cray da Costa, et al.

Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
by: Gianfranco De Girolamo, et al.
Published: (2022-04-01)

Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants
by: Jan C. Purrucker, et al.
Published: (2017-01-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
by: Adel Khalifa Sultan Hamad
Published: (2022-01-01)

Socioeconomic differences in one-year survival after ischemic stroke: the effect of acute and post-acute care-pathways in a cohort study
by: Valeria Belleudi, et al.
Published: (2016-05-01)

The Tradeoff between Travel Time from Home to Hospital and Door to Balloon Time in Determining Mortality among STEMI Patients Undergoing PCI.
by: Riccardo Di Domenicantonio, et al.
Published: (2016-01-01)

Safety of Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Patients with Chronic Kidney Disease and Kidney Transplant Recipients
by: Mikołaj Młyński, et al.
Published: (2022-06-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review
by: Larysa A. Vozniuk, et al.
Published: (2023-09-01)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
by: Mette Søgaard, et al.
Published: (2019-06-01)

Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?
by: Martin Müller, et al.
Published: (2021-04-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation
by: Jia Wang, et al.
Published: (2022-10-01)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
by: MuHyung Heo, et al.
Published: (2023-03-01)